PharmaBiota® - is an exclusive drug development platform that has enable Microviable to develop novel biotherapeutic products derived from the microbiome. This core platform encompasses microbiology, immunology, molecular biology and bioinformatics together with a large and diverse proprietary bacterial culture collection.

The vast collection on human commensal bacteria together with the deep knowledge of the microbiome after more tan 20 years of research experience has already enabled the development of tangible products and biological medicines. The extensive pipeline for data mining and bacterial characterization led to successful outcomes with defined products for specific applications.

NaturBiome is our specific area for the development of novel biotherapeutic products for skin health, including R&D and manufacturing of cosmestic bioactives derived from beneficial bacteria.

Our technology enables the selection, characterization and validation of bacterial strains and their metabolites, including postbiotics and parabiotics, with high efficacy to solve skin problems. These targeted applications enable also to restore the skin microbiome towards a healthy situation.